NASDAQ:KIDS OrthoPediatrics (KIDS) Stock Price, News & Analysis $22.58 +0.01 (+0.02%) As of 03:15 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About OrthoPediatrics Stock (NASDAQ:KIDS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OrthoPediatrics alerts:Sign Up Key Stats Today's Range$22.32▼$22.7150-Day Range$18.72▼$26.5052-Week Range$14.42▼$26.74Volume41,896 shsAverage Volume174,353 shsMarket Capitalization$589.69 millionP/E RatioN/ADividend YieldN/APrice Target$26.44Consensus RatingModerate Buy Company Overview OrthoPediatrics Corp. (NASDAQ: KIDS) develops, manufactures and sells orthopedic products designed specifically for children. The company focuses on addressing the distinct anatomical and clinical needs of pediatric patients, offering implants, instruments and related technologies for orthopedic surgery. Its product portfolio includes solutions for pediatric trauma and deformity correction, scoliosis and spinal disorders, sports medicine, limb lengthening and reconstruction, and neuromuscular conditions. The company also provides specialized surgical instruments and systems intended to support orthopedic procedures for infants, children and adolescents. Founded in 2006 and headquartered in Warsaw, Indiana, OrthoPediatrics markets its products through direct sales and distribution relationships in the United States and international markets. The company became publicly traded in 2017 and has expanded its offerings through internal development and acquisitions, including technologies focused on pediatric spine care.AI Generated. May Contain Errors. Read More OrthoPediatrics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreKIDS MarketRank™: OrthoPediatrics scored higher than 61% of companies evaluated by MarketBeat, and ranked 413th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingOrthoPediatrics has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on no strong buy ratings, 9 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialOrthoPediatrics has a consensus price target of $26.44, representing about 17.0% upside from its current price of $22.60.Amount of Analyst CoverageOrthoPediatrics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about OrthoPediatrics' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for OrthoPediatrics are expected to grow in the coming year, from ($1.14) to ($0.86) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OrthoPediatrics is -13.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of OrthoPediatrics is -13.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrthoPediatrics has a P/B Ratio of 1.64. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about OrthoPediatrics' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.98% of the float of OrthoPediatrics has been sold short.Short Interest Ratio / Days to CoverOrthoPediatrics has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in OrthoPediatrics has recently increased by 8.90%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOrthoPediatrics does not currently pay a dividend.Dividend GrowthOrthoPediatrics does not have a long track record of dividend growth. News and Social Media3.1 / 5News SentimentN/A News SentimentOrthoPediatrics has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for OrthoPediatrics this week, compared to 3 articles on an average week.Search Interest5 people have searched for KIDS on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added OrthoPediatrics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.1 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, OrthoPediatrics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $46,747,931.00 in company stock.Percentage Held by Insiders32.50% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions69.05% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about OrthoPediatrics' insider trading history. Receive KIDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KIDS Stock News HeadlinesOrthoPediatrics Surpasses 1,000 PNP Tibia Nail ImplantationsSeptember 22, 2026 | globenewswire.comOrthoPediatrics Corp.(NasdaqGM:KIDS) added to S&P Healthcare Equipment Select Industry IndexSeptember 21, 2026 | marketscreener.comMSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.September 29 at 1:00 AM | Altimetry (Ad)OrthoPediatrics Corp (KIDS) Stock Down 6.0% -- Now Undervalued? GF Score: 84/100September 17, 2026 | gurufocus.comOrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells 302,369 SharesSeptember 12, 2026 | insidertrades.comOrthoPediatrics (NASDAQ:KIDS) Director David Pelizzon Sells 302,369 SharesSeptember 11, 2026 | insidertrades.comDavid Pelizzon Sells 22,500 Shares of OrthoPediatrics (NASDAQ:KIDS) StockSeptember 5, 2026 | insidertrades.comOrthoPediatrics (NASDAQ:KIDS) Director David Pelizzon Sells 10,131 Shares of StockSeptember 2, 2026 | insidertrades.comSee More Headlines KIDS Stock Analysis - Frequently Asked Questions How have KIDS shares performed this year? OrthoPediatrics' stock was trading at $17.76 at the beginning of the year. Since then, KIDS shares have increased by 27.3% and is now trading at $22.6020. How were OrthoPediatrics' earnings last quarter? OrthoPediatrics Corp. (NASDAQ:KIDS) issued its quarterly earnings results on Tuesday, August, 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.04. The business earned $70.51 million during the quarter, compared to analyst estimates of $68.21 million. OrthoPediatrics had a negative net margin of 15.72% and a negative trailing twelve-month return on equity of 8.10%. Read the conference call transcript. When did OrthoPediatrics IPO? OrthoPediatrics (KIDS) raised $52 million in an initial public offering (IPO) on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers. How do I buy shares of OrthoPediatrics? Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of OrthoPediatrics own? Based on aggregate information from My MarketBeat watchlists, some other companies that OrthoPediatrics investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and AUO (AUOTY). Company Calendar Last Earnings8/04/2026Today9/29/2026Next Earnings (Estimated)10/27/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 KIDS's financial health is in the Green zone, according to TradeSmith. KIDS has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:KIDS CIK1425450 Webwww.orthopediatrics.com Phone(574) 268-6379Fax574-269-3692Employees602Year Founded2006Price Target and Rating Average Price Target for OrthoPediatrics$26.44 High Price Target$35.00 Low Price Target$20.00 Potential Upside/Downside+16.7%Consensus RatingModerate Buy Rating Score (0-4)2.73 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)($1.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$39.65 million Net Margins-15.72% Pretax Margin-15.61% Return on Equity-8.10% Return on Assets-5.54% Debt Debt-to-Equity Ratio0.28 Current Ratio4.78 Quick Ratio2.17 Sales & Book Value Annual Sales$236.35 million Price / Sales2.50 Cash Flow$0.17 per share Price / Cash Flow135.61 Book Value$13.82 per share Price / Book1.64Miscellaneous Outstanding Shares26,110,000Free Float17,624,000Market Cap$591.47 million OptionableOptionable Beta0.99 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:KIDS) was last updated on 9/29/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OrthoPediatrics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OrthoPediatrics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
